StonvexLoading…
StonvexStonvexStonvexCore line items from IMRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-58.41M | $-42.11M | $-28.18M | $-14.68M |
Net Income | $-53.47M | $-38.39M | $-12.19M | $-13.60M |
EPS (Diluted) | $-1.88 | $-1.36 | $-0.94 | $-0.51 |
Total Assets | $102.58M | $113.88M | $124.90M | $107.70M |
Total Liabilities | $12.01M | $9.86M | $9.79M | $9.91M |
Cash & Equivalents | $59.41M | $68.04M | $104.02M | $77.43M |
Free Cash Flow OCF − CapEx | $-49.31M | $-37.37M | $-25.28M | $-14.45M |
Shares Outstanding | 28.42M | 28.13M | 27.55M | 26.44M |